Wuhan Hiteck Biological Overview

  • Status
  • Public

  • Employees
  • 1,143

  • Stock Symbol
  • 300683

Stock Symbol
  • Investments
  • 1

  • Share Price
  • $5.64

  • (As of Monday Closing)

Wuhan Hiteck Biological General Information


Wuhan Hiteck Biological Pharma Co Ltd is a biopharmaceutical manufacturing enterprise in China. The company is primarily engaged in the development, production and sale of biological products. Its product portfolio comprises rat nerve growth factor freeze-dried powder injection, injection of anti-hepatitis B transfer factor freeze-dried powder injection, thrombin and other chemicals. The company also has more than 20 kinds of products such as hepatitis B treatment drug op Heparin and hemostatic agent thrombin.

Contact Information

Ownership Status
Publicly Held
Financing Status
Primary Industry
Drug Discovery
Stock Exchange
Primary Office
  • Hite Science and Technology Park
  • Wuhan Economic Development Zone
  • Wuhan, Hubei 430056
  • China
+86 027 0000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Wuhan Hiteck Biological Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$5.64 $5.59 $4.47 - $9.56 $689M 122M 1.14M $0.04

Wuhan Hiteck Biological Financials Summary

In Thousands,
TTM 30-Sep-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 503,505 985,621 488,621 281,912
Revenue 117,312 95,195 75,865 89,753
EBITDA 2,675 7,010 (4,164) 12,198
Net Income 4,247 4,283 (3,622) 9,123
Total Assets 375,444 423,199 335,828 310,980
Total Debt 14,617 17,419 2,141 26,479
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Wuhan Hiteck Biological Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Wuhan Hiteck Biological Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Wuhan Hiteck Biological‘s full profile, request access.

Request a free trial

Wuhan Hiteck Biological Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000 000000000 21-Jul-2021 00000 0000 00.000 Drug Discovery
To view Wuhan Hiteck Biological’s complete investments history, request access »